MARKET

AMRN

AMRN

Amarin
NASDAQ

Real-time Quotes | Nasdaq Last Sale

24.12
+1.13
+4.92%
Suspension 16:41 12/13 EST
OPEN
23.00
PREV CLOSE
22.99
HIGH
24.17
LOW
23.00
VOLUME
7.75M
TURNOVER
--
52 WEEK HIGH
24.67
52 WEEK LOW
11.78
MARKET CAP
8.66B
P/E (TTM)
-122.5610
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMRN and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 10 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AMRN News

  • Amarin gets FDA approval for new Vascepa use, U.S. shares remain halted
  • MarketWatch.29m ago
  • Amarin Sees 2019 VASCEPA Net Revenue $410M-$425M, Sees 2020 VASCEPA Net Revenue $650M-$700M
  • Benzinga.30m ago
  • Amarin Receives FDA Approval Of VASCEPA To Reduce Cardiovascular Risk
  • Benzinga.31m ago
  • Amarin Receives FDA Approval of VASCEPA® (icosapent ethyl) to Reduce Cardiovascular Risk
  • GlobeNewswire.33m ago

More

Industry

Biotechnology & Medical Research
-0.88%
Pharmaceuticals & Medical Research
+0.01%

Hot Stocks

Name
Price
%Change

About AMRN

Amarin Corporation plc is a biopharmaceutical company with operations in lipid science focused on the commercialization and development of therapeutics for cardiovascular health. The Company operates through the development and commercialization of Vascepa segment. The Company's lead product, Vascepa (icosapent ethyl) capsule, is approved by the United States Food and Drug Administration (FDA) for use as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
More

Webull offers Amarin Corporation plc (ADR) (AMRN) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.